A mutation in BRAF gene is found in approximately 50% of melanoma, resulting in a constitutive activation of RAF-MEK-MAPK pathway, leading to cellular proliferation, survival and differentiation [21]. This evidence concerns the gene MAP2K7 and melanoma.